Zhejiang Xianju Pharmaceutical Co., Ltd. (SHE:002332)
China flag China · Delayed Price · Currency is CNY
8.73
-0.08 (-0.91%)
Sep 10, 2026, 3:04 PM CST

SHE:002332 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
385.93449.64397.18563.08749.41619.33
Depreciation & Amortization
215.69218.95226.74218.91193189.52
Other Amortization
9.266.41.932.272.744.32
Loss (Gain) From Sale of Assets
0.02-46.3-0.281.48-91.62-14.51
Asset Writedown & Restructuring Costs
7.311.821.310.420.911.68
Loss (Gain) From Sale of Investments
33.6426.418.087.17-49.35-29.22
Provision & Write-off of Bad Debts
9.875.4410.95-7.294-
Other Operating Activities
60.8350.3239.3142.5332.3825.45
Change in Accounts Receivable
-140.72-275.98-280.88-203.22-129.7769.04
Change in Inventory
31.5-6.4-88.14-105.98-92.65-233.44
Change in Accounts Payable
-1.39-178.1289.669.36-9.7924.19
Operating Cash Flow
607.62247.48398.66595.48609.28657.9
Operating Cash Flow Growth
100.52%-37.92%-33.05%-2.27%-7.39%-16.64%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-155.93-209.07-207.59-234.63-282.54-248.58
Sale of Property, Plant & Equipment
1.770.7647.261.314.0337.74
Divestitures
10.4610.46-48.2269.88-
Investment in Securities
1.71.71-24.3-16.33507.046.53
Other Investing Activities
3.85-4.214.8159.67-0.38
Investing Cash Flow
-138.15-196.14-180.42-196.63358.07-204.68

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Short-Term Debt Issued
--3.45---
Long-Term Debt Issued
-414.955.621.36198.15433.79
Total Debt Issued
260.95414.959.071.36198.15433.79
Long-Term Debt Repaid
--276-174.03-158.86-584.73-808.94
Lease Payments
-3.46-5.05-4.5-10.39-6.08-5.54
Net Debt Issued (Repaid)
-212.34138.95-164.97-157.5-386.58-375.16
Common Dividends Paid
-302.53-401.51-298.19-299.77-154.22-172.13
Other Financing Activities
-6.481.35-2.67-6.58118.3663.15
Financing Cash Flow
-555.89-261.21-465.82-463.85-422.44-484.13

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-49.2425.61-6.13-13.4428.17-32.71
Net Cash Flow
-135.65-184.26-253.72-78.43573.09-63.64

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
451.6938.4191.07360.85326.74409.31
Free Cash Flow Growth
659.10%-79.90%-47.05%10.44%-20.17%-39.01%
Free Cash Flow Margin
11.74%1.02%4.78%8.75%7.46%9.39%
Free Cash Flow Per Share
0.450.040.190.360.330.41
Levered Free Cash Flow
362.75168.48136.88389.58279.35310.37
Unlevered Free Cash Flow
365.47171.38138.84391.68283.28324.81
Free Cash Flow After Leases
448.2433.35186.56350.46320.66403.77

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
311.06293.96254.06286.67423.25380.93
Change in Working Capital
-114.92-465.21-286.56-233.08-232.19-138.66